白癜风发病与进展中CXCL12与CCL5趋化信号失衡
研究检测了早期(≤2个月)与进展期(≥6个月)白癜风患者培养黑素细胞及皮损的趋化特征,发现早期皮损黑素细胞CXCL12与CCL5分泌升高,伴抗原提呈细胞与T细胞浸润;动物实验证实这些趋化因子招募免疫细胞并导致白斑样病变,提示抑制该趋化轴或可稳定白癜风。
要点
- 早期白癜风黑素细胞CXCL12与CCL5分泌升高,与免疫细胞浸润同步出现。
- 皮损内抗原提呈细胞多表达CD86并与T细胞共定位,早期病变更明显。
- 靶向CXCL12与CCL5趋化轴可能成为稳定白癜风的策略。
核心结论
- 黑素细胞来源的CXCL12与CCL5支持抗原提呈细胞和T细胞招募、抗原获取及T细胞活化,参与白癜风早期免疫激活,抑制这些趋化轴有望稳定病情。
研究设计与样本
- 研究检测了培养的白癜风黑素细胞及早期(≤2个月)与进展期(≥6个月)白癜风皮损的趋化特征,并结合动物移植实验验证。
主要发现
- 早期皮损黑素细胞多种趋化相关分子表达改变,CXCL12与CCL5分泌升高。
- 这些趋化因子升高与皮损内抗原提呈细胞和T细胞明显浸润同时出现。
- 皮损内多数抗原提呈细胞表达CD86并与T细胞共定位,早期病变更显著。
- 动物实验显示抗原提呈细胞和T细胞优先募集至表达CXCL12与CCL5的移植黑素细胞,并出现色素细胞持续丢失及白斑样病变。
临床怎么用
- 提示CXCL12与CCL5趋化轴可作为白癜风早期干预与稳定治疗的潜在靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Generalized nonsegmental vitiligo is often associated with the activation of melanocyte-specific autoimmunity. Because chemokines play an important role in the maintenance of immune responses, we examined chemotactic signatures in cultured vitiligo melanocytes and skin samples of early (≤2 months) and advanced (≥6 months) vitiligo. Analysis showed that melanocytes in early lesions have altered expression of several chemotaxis-associated molecules, including elevated secretion of CXCL12 and CCL5. Higher levels of these chemokines coincided with prominent infiltration of the skin with antigen presenting cells (APCs) and T cells. Most of the intralesional APCs expressed the CD86 maturation marker and co-localized with T cells, particularly in early vitiligo lesions. These observations were confirmed by in vivo animal studies showing preferential recruitment of APCs and T cells to CXCL12- and CCL5-expressing transplanted melanocytes, immunotargeting of the chemokine-positive cells, continuous loss of the pigment-producing cells from the epidermis, and development of vitiligo-like lesions. Taken together, our studies show that melanocyte-derived CXCL12 and CCL5 support APC and T-cell recruitment, antigen acquisition, and T-cell activation in early vitiligo and reinforce the role of melanocyte-derived CXCL12 and CCL5 in activation of melanocyte-specific immunity and suggest inhibition of these chemotactic axes as a strategy for vitiligo stabilization.
引用
- Rezk AF, Kemp DM, El-Domyati M, et al. Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression. J Invest Dermatol. 2017. PMID: 28132854. doi:10.1016/j.jid.2016.12.028
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。